Nanostructures for drug delivery / / edited by Ecaterina Andronescu, University Politehnica of Bucharest, Bucharest, Romania, Alexandru Mihai Grumezescu, University Politehnica of Bucharest, Bucharest, Romania |
Autore | Andronescu Ecaterina |
Edizione | [1st edition] |
Pubbl/distr/stampa | Amsterdam, Netherlands : , : Elsevier, , [2017] |
Descrizione fisica | 1 online resource (xxxvii, 985 pages) : illustration (some color) |
Disciplina | 620.5 |
Collana | Nanostructures in Therapeutic Medicine Series |
Soggetto topico |
Nanomedicine
Nanoparticles Drug delivery systems |
ISBN |
0-323-46149-2
0-323-46143-3 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | ch. 1. Therapeutic nanomaterials : from a drug delivery perspective / Chityal Ganesh Kumar, Yedla Poornachandra, Sujitha Pombala -- ch. 2. Core-shell drug carriers : liposomes, polymersomes, and niosomes / Nily Dan -- ch. 3. The new nanocarriers based on graphene and graphene oxide for drug delivery applications / Somayeh Mohamadi, Mehrdad Hamidi -- ch. 4. Nanostructured nanoparticles for improved drug delivery / Jean M. Rabanel [and four others] -- ch. 5. Design of functionalized materials for use in micronanoscale drug delivery devices and smart patches / Ashleigh Anderson, James Davis -- ch. 6. Niosomes : a novel approach in modern drug delivery systems / Sepideh Khoee, Morteza Yaghoobian -- ch. 7. Nanofibrous and nanoparticle materials as drug-delivery systems / Fatemeh Zamani [and six others] -- ch. 8. Brush polymer-based nanostructures for drug delivery / Yun Yu, Haotian Sun, Chong Cheng -- ch. 9. Drug delivery systems based on titania nanostructures / Magdalena Jarosz [and four others] -- ch. 10. Redox activated polymeric nanoparticles in tumor therapy / Houman Alimoradi [and four others] -- ch. 11. Polymeric micro- and nanoparticles for controlled and targeted drug delivery / Magdalena Stevanovic -- ch. 12. Novel gels : implications for drug delivery / Swarnali D. Paul [and three others] -- ch. 13. Nanosuspension drug delivery system : preparation, characterization, postproduction processing, dosage form, and application / Jiuhong Zhang [and three others] -- ch. 14. Polymer-based nanocarriers for therapeutic nucleic acids delivery / Weien Yuan, Hui Li -- ch. 15. Multifunctional therapeutic hybrid nanocarriers for targeted and triggered drug delivery : recent trends and future prospects / Gulbin Kurtay [and three others] -- ch. 16. Lipid-based nanocarriers for ocular drug delivery / Ragwa M. Farid [and three others] -- ch. 17. Nanoparticulate carrier(s) : an emerging paradigm in new generation vaccine development / Rajeev Sharma [and three others] -- ch. 18. Pathogen-specific nucleic acid aptamers as targeting components of antibiotic and gene delivery systems / Canan Ozyurt [and three others] -- ch. 19. Multifunctional nanosized emulsions for theragnosis of life threatening diseases / Tamilvanan Shunmugaperumal, Raja Sekharan Thenrajan, Ruchi Sharma -- ch. 20. Therapeutic nanostructures for pulmonary drug delivery / Yousef Javadzadeh, Shadi Yaqoubi -- ch. 21. Nanostructures in transdermal drug delivery systems / Najma Bibi, Naveed Ahmed, Gul Majid Khan -- ch. 22. Advancement in pulmonary drug delivery systems for treatment of tuberculosis / Amit K. Goyal [and three others] -- ch. 23. Nanosized devices as antibiotics and antifungals delivery : past, news, and outlook / Pio Maria Furneri [and four others] -- ch. 24. Drug delivery mediated by confined nanosystems : structure-activity relations and factors responsible for the efficacy of formulations / Lucia Zakharova [and four others] -- ch. 25. Therapeutic use of monoclonal antibodies : general aspects and challenges for drug delivery / Daniela A. Quinteros [and five others] -- ch. 26. Targeted drug delivery via chitosan-coated magnetic nanoparticles / Gozde Unsoy, Ufuk Gunduz -- ch. 27. Drug delivery : advancements and challenges / Narinder Singh [and three others] -- ch. 28. Stimuli-responsive liposome and control release drug / Xueqin An, Rijun Gui -- ch. 29. Nanotechnology to enhance transdermal delivery of hydrophilic humectants for improved skin care : a model for therapeutic applications / Steven Dominguez, Gina A. Mackert, Marek K. Dobke -- ch. 30. Nanostructures for drug delivery : pharmacokinetic and toxicological aspects / Adrian G. Ciuca [and seven others]. |
Record Nr. | UNINA-9910583498103321 |
Andronescu Ecaterina
![]() |
||
Amsterdam, Netherlands : , : Elsevier, , [2017] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Nanostructures for oral medicine / / edited by Ecaterina Andronescu, Alexandru Mihai Grumezescu |
Pubbl/distr/stampa | Amsterdam, [Netherlands] : , : Elsevier, , 2017 |
Descrizione fisica | 1 online resource (1,036 pages) : illustrations |
Disciplina | 610.28 |
Collana | Micro and Nano Technologies |
Soggetto topico |
Nanomedicine
Oral medicine Nanostructured materials - Therapeutic use |
ISBN | 0-323-47721-6 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910583081903321 |
Amsterdam, [Netherlands] : , : Elsevier, , 2017 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Nanotechnologies in preventive and regenerative medicine / / edited by Vuk Uskokovićc, Dragan P. Uskokovićc |
Pubbl/distr/stampa | Amsterdam, Netherlands ; ; Oxford, England ; ; Cambridge, Massachusetts : , : Elsevier, , 2018 |
Descrizione fisica | 1 online resource (591 pages) : illustrations (some color) |
Disciplina | 610.28 |
Collana | Micro and Nano Technologies Series |
Soggetto topico |
Nanomedicine
Medicine, Preventive |
ISBN |
0-323-48064-0
0-323-48063-2 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910583460403321 |
Amsterdam, Netherlands ; ; Oxford, England ; ; Cambridge, Massachusetts : , : Elsevier, , 2018 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Nanotechnology applications in health and environmental sciences / / Necdet Saglam, Feza Korkusuz, Ram Prasad, editors |
Edizione | [1st ed. 2021.] |
Pubbl/distr/stampa | Cham, Switzerland : , : Springer, , [2021] |
Descrizione fisica | 1 online resource (XIV, 439 p. 77 illus., 62 illus. in color.) |
Disciplina | 610.28 |
Collana | Nanotechnology in the Life Sciences |
Soggetto topico |
Nanomedicine
Nanomedicina Nanotecnologia Medi ambient |
Soggetto genere / forma | Llibres electrònics |
ISBN | 3-030-64410-3 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Preface -- Diverse Manifolds of Biogenic Nanoparticles in Synthesis, Characterization and Applications -- Impact of Nanoparticles on Human Microbiota -- In-Vitro Applications of Nanoparticles -- Nanoparticles for Anticancer Drug Delivery -- Application of Nanotechnology in the Treatment of Microbial Infections -- Metal Organic Framework: Applications in Nanomedicine -- Recent Advances in Nanomaterial-Based Diagnosis and Treatment -- Nanobiosensors for Biomedical Applications -- Emerging Role of Nanomaterial Assisted Bio-Sensors for Circulating Tumor Cells Detection -- Advanced Functional Polymers for Biomedical Applications -- SERS Sensor Applications in Environmental Analysis and Biotechnology -- Design and Creation of Micro and Nano Environment in Regenerative and Restorative Medicine -- Presenting and Treating Bone Infections Using Silver-Ion Containing Nano-Hydroxyapatite -- Trace Element Containing Nano-HAp for Preventing Musculoskeletal Infections -- Biotechnological Approaches in Maintenance of a Healthy Immune System for Protection Against Diseases -- Production and Characterization of Antibiotic-Containing Nano-Calcium Phosphates -- Lantibiotics Nanotechnology, Bioengineering and Biotechnology -- Microbial Biotechnology and Postmortem Diagnosis -- Clean-Up and Pollution with Nanoparticles: An Environmental Dillemma -- Environmental Myco-Nanobiotechnology and Fungal Bioremediation -- Application of Nanotechnology in Detection and Diagnosis of Plant Diseases -- Index. |
Record Nr. | UNINA-9910484264003321 |
Cham, Switzerland : , : Springer, , [2021] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Nanotechnology for biomedical applications / / Sreerag Gopi, Preetha Balakrishnan and Nabisab Mujawar Mubarak, editors |
Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore Pte Ltd., , [2022] |
Descrizione fisica | 1 online resource (499 pages) |
Disciplina | 610.28 |
Collana | Materials horizons |
Soggetto topico |
Biomedical engineering
Nanobiotechnology Nanomedicine |
ISBN |
981-16-7482-5
981-16-7483-3 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910743345403321 |
Singapore : , : Springer Nature Singapore Pte Ltd., , [2022] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Nanotechnology for infectious diseases / / edited by Saif Hameed and Suriya Rehman |
Pubbl/distr/stampa | Gateway East, Singapore : , : Springer, , [2022] |
Descrizione fisica | 1 online resource (638 pages) |
Disciplina | 616.90475 |
Soggetto topico | Nanomedicine |
ISBN |
981-16-9190-8
981-16-9189-4 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Intro -- Foreword by Dr. Shahid Jameel -- Foreword by Prof. Abdulhadi Baykal -- Preface -- Contents -- About the Editors -- Part I: Infectious Diseases -- 1: A Holistic View of Human Infectious Diseases: Challenges and Opportunities -- 1.1 Overview -- 1.2 Chain of Infection -- 1.2.1 Infectious Agents -- 1.2.2 Reservoir -- 1.2.3 Modes of Escape -- 1.2.4 Mode of Transmission -- 1.2.5 Direct Contact -- 1.2.5.1 Droplet Transmission -- 1.2.5.2 Indirect Transmission -- Airborne Transmission -- Vehicle Borne Transmission -- Vector Borne Transmission -- 1.2.6 Portal of Entry -- 1.2.7 Susceptible Host -- 1.3 Emerging and Re-emerging Diseases -- 1.3.1 Re-emerging Infectious Diseases -- 1.3.2 Factors Contributing to Emergence or Re-emergence of Infectious Diseases -- 1.3.3 Globalization, Trade, and Travelling -- 1.3.4 Environmental and Ecological Changes -- 1.3.5 Human-Reservoir (Wild Animal) Interface -- 1.3.6 Adaptations and Changes of Microbial Agents/Antibiotic Resistance -- 1.4 Interventions for Infectious Disease Control and Prevention -- 1.4.1 Antimicrobials/Antibiotics -- 1.4.2 Vaccines -- 1.4.3 Public Health Priority for Infection Control -- 1.5 New Strategies and Hopes -- 1.5.1 Nanotechnology and Nanobiology -- 1.5.2 Gene Sequencing to Inform Infection Control -- 1.5.3 Data Handling and Simulation Systems -- 1.5.4 Healthcare Reforms -- 1.6 Conclusion -- References -- 2: Application of Nanotechnology in the Treatment of Infectious Diseases: An Overview -- 2.1 Introduction -- 2.2 Nano Formulations for the Treatment of Bacterial Infections -- 2.3 Nano Formulations for the Treatment of Fungal Infections -- 2.4 Application of Nanotechnology Against Viral Infections -- 2.5 Nanotechnology in Drug Delivery Targeting Infectious Diseases -- 2.6 Nanomaterials Vaccines for Infectious Diseases.
2.7 Nanomaterials in Photothermal Therapy Against Infectious Pathogens -- 2.8 Application of Nanodiamonds in Infectious Diseases -- 2.9 Synergistic Antimicrobial Potentials of Nanomaterials/Nanocomposite in Combination with Other Antimicrobial Agents Against... -- 2.10 Challenges and Future Perspectives -- 2.11 Conclusion -- References -- 3: Understanding the Pharmacology and Pharmacotherapeutics for Infectious Diseases -- 3.1 Introduction -- 3.2 Transmission of Infectious Diseases -- 3.3 Infectious Diseases -- 3.3.1 Bacterial Diseases -- 3.3.2 Fungal Infections -- 3.3.3 Viral Infections -- 3.3.4 Parasitic Infections -- 3.4 Emerging Infectious Diseases -- 3.5 Pharamacotherapeutic Interventions -- 3.5.1 Antibiotics -- 3.5.1.1 Beta Lactam Antibiotics -- 3.5.1.2 Fluoroquinolones -- 3.5.2 Antifungals -- 3.5.3 Antivirals -- 3.5.3.1 Antiviral Targeting the Viral Proteins -- 3.5.3.2 Antivirals Targeting the Host Proteins -- 3.5.4 Antiparasitic Drugs -- 3.6 Nanomedicine -- 3.6.1 Types of Nanoparticles Used in Nanomedicine -- 3.6.1.1 Organic Nanoparticles -- 3.6.1.2 Inorganic Nanoparticles -- 3.6.2 Nanoparticles in Infectious Diseases -- 3.7 Conclusion -- References -- Part II: Nanomaterials as Anti-infection Therapeutics -- 4: Advanced Nanomaterials for Infectious Diseases Therapeutics -- 4.1 Metal-Based Nanoparticles -- 4.1.1 Silver Nanoparticles -- 4.1.2 Gold Nanoparticles -- 4.1.3 Iron-Oxide Based Nanoparticles -- 4.1.4 Zinc Oxide Nanoparticles -- 4.1.5 Copper Oxide Nanoparticles -- 4.2 Encapsulated Nanoparticles -- 4.2.1 Polymer/Dendrimer Encapsulation -- 4.2.2 Metal Encapsulation -- 4.3 Nanoantibiotics -- 4.4 Conclusions and Future Trend -- References -- 5: Metal-Based Nanoparticles for Infectious Diseases and Therapeutics -- 5.1 Introduction -- 5.2 Bacteria and Antibacterial Drug -- 5.3 Metal-Based Nanoparticles. 5.3.1 Synthesis, Characterization, and Properties of Metal-Based Nanoparticles -- 5.3.2 Classification of Metal-Based Nanoparticles -- 5.3.3 Metal Nanoparticles Against Infectious Diseases -- 5.3.4 Metal Oxide Nanoparticles Against Infectious Diseases -- 5.3.5 Metal Sulfide Nanoparticles Against Infectious Diseases -- 5.4 General Mechanism of Metal-Based Nanoparticles Against Infectious Diseases -- 5.5 Factors Affecting the Antimicrobial Activities of Nanoparticles -- 5.6 Conclusion -- References -- 6: The Future Therapy of Nanomedicine Against Respiratory Viral Infections -- 6.1 Introduction -- 6.2 Viruses Classification According to the Genetic Materials -- 6.3 The Threat of Respiratory Viral Infections -- 6.3.1 The SARS-CoV-2 Threat -- 6.3.2 Toxicity of Conventional Antiviral Drugs -- 6.4 Nanodrugs and Their Efficacy in Killing Viruses -- 6.4.1 Nanomedicine Weapon Against SARS-CoV-2 Threat -- 6.4.2 Biogenic and Non-biogenic Metallic Nanoparticles and Its Antiviral Efficiency -- 6.4.3 The Antiviral Activity of Organic Nanoparticles -- 6.4.3.1 Polymeric Nanoparticles -- 6.4.3.2 Carbon-Based Nanomaterials as Antivirals -- 6.4.3.3 Lactoferrin Loaded Nanoparticles as Antivirals -- 6.4.3.4 Silica Nanocarriers as Antivirals -- 6.5 Conclusion -- References -- 7: Application of Nanoparticles to Invasive Fungal Infections -- 7.1 Introduction -- 7.2 Antifungal Therapy -- 7.2.1 Azole Compounds -- 7.2.2 Pyrimidine Analogous -- 7.2.3 Polyenes -- 7.2.4 Echinocandins -- 7.3 Nanoformulations for Antifungal Therapy -- 7.3.1 Polymeric Nanoparticles -- 7.3.2 Metallic Nanoparticles -- 7.3.3 Lipid Nanoparticles -- 7.4 Systemic Mycoses and Nanotechnology -- 7.4.1 Candida sp. -- 7.4.1.1 Polymeric Nanoparticles -- 7.4.1.2 Lipid Nanoparticles -- 7.4.2 Aspergillus sp. -- 7.4.2.1 Polymeric Nanoparticles -- 7.4.3 Cryptococcus sp. -- 7.4.3.1 Polymeric Nanoparticles. 7.4.3.2 Metallic Nanoparticles -- 7.4.3.3 Lipid Nanoparticles -- 7.4.4 Paracoccidioides sp. -- 7.4.4.1 Polymeric Nanoparticles -- Polymeric Nanoparticles Used in Vaccines -- 7.4.4.2 Metallic Nanoparticles -- 7.4.4.3 Lipid Nanoparticles -- 7.5 Conclusion -- References -- 8: Nanomaterials in the Diagnosis and Treatment of Leishmaniasis -- 8.1 Introduction -- 8.2 Available Chemotherapeutic Drugs for Leishmaniasis -- 8.2.1 Pentavalent Antimonial -- 8.2.2 Pentamidine -- 8.2.3 Amphotericin B -- 8.2.4 Miltefosine -- 8.2.5 Paromomycin -- 8.2.6 Sitamaquine -- 8.2.7 Other New Antileishmanial Molecules -- 8.3 Conventional Methods for Detection of Leishmaniasis -- 8.4 Nanomaterials in the Diagnosis of Leishmaniasis -- 8.5 Nanomaterials in the Therapy and Protection Against Leishmania spp. Infection -- 8.5.1 Antileishmanial Nanoparticles and Nanopreparations -- 8.5.2 Nanomaterials in the Development of Vaccine Against Leishmaniasis -- 8.6 Conclusion -- References -- 9: A Comprehensive Review on the Synthesis, Surface Decoration of Nanoselenium and Their Medical Applications -- 9.1 Introduction -- 9.2 Chemical Synthesis of SeNPs -- 9.2.1 Chemical Reduction Methods -- 9.2.2 Wet Chemical Method -- 9.2.3 Hydrothermal Methods -- 9.2.4 Solvothermal Method -- 9.2.5 Sol-Gel Method -- 9.3 Physical Synthesis of SeNPs -- 9.3.1 Lser bltin -- 9.3.2 Microwave Irradiation Method -- 9.3.3 Sonochemical (Ultrasonic) -- 9.3.4 Gamma Radiation -- 9.3.5 Low Temperature Reactive Aerosol Processing -- 9.3.6 Heterogeneous Condensation Method -- 9.3.7 Ball Milling Method -- 9.4 Biological Synthesis of SeNPs -- 9.5 Antimicrobial Activity and Mechanism of SeNPs -- 9.6 Surface Decoration of SeNPs -- 9.6.1 5-Fluorouracil (5-FU) -- 9.6.2 Polyporus rhinoceros -- 9.6.3 Chitosan -- 9.6.4 Other Amino Acids -- 9.6.5 Proteins or Polypeptide -- 9.6.6 Natural Products -- 9.7 Conclusion -- References. Part III: Nanotechnology and Drug Carriers -- 10: Nanotechnology in Drug Delivery Systems: Ways to Boost Bioavailability of Drugs -- 10.1 Introduction -- 10.2 Nanotechnology Oriented Drug Delivery Systems -- 10.3 Nanoparticles as Drug Carrier -- 10.4 Quantum Dots Nanocarriers -- 10.5 Electrospun Nanofibers as Carriers -- 10.6 Nanoemulsions for Delivery of Drugs -- 10.7 Nanohydrogel Delivery Systems -- 10.8 Conclusion -- References -- 11: Recent Developments in Silica Nanoparticle Based Drug Delivery System -- 11.1 Introduction -- 11.2 Types of Silica Nanoparticles -- 11.3 Non-porous Silica Nanoparticle -- 11.4 Mesoporous Silica Nanoparticles -- 11.5 Core/Shell Silica Nanoparticles -- 11.6 Synthesis of Silica Nanoparticles -- 11.7 Mesoporous Silica Nanoparticles as Drug Delivery System -- 11.8 pH Responsive MSN Based Carrier System -- 11.9 Redox Responsive Nanocarrier -- 11.10 Enzyme Responsive Nanocarrier -- 11.11 Silica Nanoparticle as a DDS for Infectious Diseases -- 11.12 Beneficial Attributes of NPs for Treatment of Infectious Diseases -- 11.13 Specific Properties of MSN Due to Which they are Used as a Nanocarrier for Infectious Disease Treatment -- 11.14 Biocompatibility, Biodistribution, and Clearance of Silica Nanoparticles -- References -- 12: Nano Drug Delivery Approaches for Lymphatic Filariasis Therapeutics -- 12.1 Introduction -- 12.2 Pathophysiological Aspects of Lymphatic Filariasis and Drug Based Targeting -- 12.3 Nanomedicine as Advanced Tool for Targeting -- 12.3.1 Nanotechnology for Overcoming Anatomical Barriers -- 12.3.1.1 In the Treatment of Adult Stage Filariasis Through Targeted Nano Drug Delivery System -- 12.3.1.2 Nanotherapeutic Amplification of MIF Effectiveness to Stop the Conduction of Lymphatic Filariasis -- 12.3.2 Nanotechnology as Enhancing the Physiochemical Properties. 12.3.2.1 Nanoscientific Elucidation for Poor Solubility of Anti-filarial Agents. |
Record Nr. | UNINA-9910743343003321 |
Gateway East, Singapore : , : Springer, , [2022] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Nanotechnology for the regeneration of hard and soft tissues [[electronic resource] /] / editor, Thomas J Webster |
Pubbl/distr/stampa | Singapore, : World Scientific, c2007 |
Descrizione fisica | 1 online resource (xxi, 237 p. ) : ill. (some col.) |
Disciplina | 616.027 |
Altri autori (Persone) | WebsterThomas J |
Soggetto topico |
Nanomedicine
Soft tissue injuries Bone regeneration |
Soggetto genere / forma | Electronic books. |
ISBN |
1-281-93811-4
9786611938116 981-277-965-5 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Promise of Nanotechnology for Implants (T Webster); Nanoceramics for Regenerating Bone (G Balasundrum); Anodization for Creating Highly Nanostructured Metals (C Yao); Polymer/Ceramic Composites for Orthopedic Implants (H Liu); Nanostructured Polymers for Vascular Applications (D Miller); Polymers with Nanofeatures for Cartilage Applications (G Jun); Carbon Nanotubes/Nanofibers for the Central and Peripheral Nervous System (J McKenzie); Bladder Nanostructured Polymers (K Haberstroh); Future Directions in Nanotechnology for Implants (T Webster). |
Record Nr. | UNINA-9910451206103321 |
Singapore, : World Scientific, c2007 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Nanotechnology for the regeneration of hard and soft tissues [[electronic resource] /] / editor, Thomas J Webster |
Pubbl/distr/stampa | Singapore, : World Scientific, c2007 |
Descrizione fisica | 1 online resource (xxi, 237 p. ) : ill. (some col.) |
Disciplina | 616.027 |
Altri autori (Persone) | WebsterThomas J. <1971-> |
Soggetto topico |
Nanomedicine
Soft tissue injuries Bone regeneration |
ISBN |
1-281-93811-4
9786611938116 981-277-965-5 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Promise of Nanotechnology for Implants (T Webster); Nanoceramics for Regenerating Bone (G Balasundrum); Anodization for Creating Highly Nanostructured Metals (C Yao); Polymer/Ceramic Composites for Orthopedic Implants (H Liu); Nanostructured Polymers for Vascular Applications (D Miller); Polymers with Nanofeatures for Cartilage Applications (G Jun); Carbon Nanotubes/Nanofibers for the Central and Peripheral Nervous System (J McKenzie); Bladder Nanostructured Polymers (K Haberstroh); Future Directions in Nanotechnology for Implants (T Webster). |
Record Nr. | UNINA-9910777016603321 |
Singapore, : World Scientific, c2007 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Nanotechnology for the regeneration of hard and soft tissues [[electronic resource] /] / editor, Thomas J Webster |
Pubbl/distr/stampa | Singapore, : World Scientific, c2007 |
Descrizione fisica | 1 online resource (xxi, 237 p. ) : ill. (some col.) |
Disciplina | 616.027 |
Altri autori (Persone) | WebsterThomas J. <1971-> |
Soggetto topico |
Nanomedicine
Soft tissue injuries Bone regeneration |
ISBN |
1-281-93811-4
9786611938116 981-277-965-5 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Promise of Nanotechnology for Implants (T Webster); Nanoceramics for Regenerating Bone (G Balasundrum); Anodization for Creating Highly Nanostructured Metals (C Yao); Polymer/Ceramic Composites for Orthopedic Implants (H Liu); Nanostructured Polymers for Vascular Applications (D Miller); Polymers with Nanofeatures for Cartilage Applications (G Jun); Carbon Nanotubes/Nanofibers for the Central and Peripheral Nervous System (J McKenzie); Bladder Nanostructured Polymers (K Haberstroh); Future Directions in Nanotechnology for Implants (T Webster). |
Record Nr. | UNINA-9910823275003321 |
Singapore, : World Scientific, c2007 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Nanotechnology in diagnosis, treatment and prophylaxis of infectious diseases / / edited by Mahendra Rai, Biotechnology Department, SGB Amravati University, Amravati, Maharashtra, India, Kateryna Kon, Department of Microbiology, Virology and Immunology, Kharkiv National Medical University, Kharkiv, Ukraine |
Pubbl/distr/stampa | Amsterdam : , : Elsevier, , [2015] |
Descrizione fisica | 1 online resource (361 p.) |
Disciplina | 612.8252 |
Soggetto topico |
Nanotechnology - Health aspects
Medical technology Nanomedicine Communicable diseases |
ISBN | 0-12-801317-6 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
""Front Cover""; ""Nanotechnology in Diagnosis, Treatment and Prophylaxis of Infectious Diseases""; ""Copyright Page""; ""Contents""; ""List of Contributors""; ""Preface""; ""1 Gold and Silver Nanoparticles for Diagnostics of Infection""; ""1.1 Nanotechnology and Infection""; ""1.2 Gold and Silver NPs for Molecular Diagnostics""; ""1.2.1 Biomarkers""; ""1.3 Nanodiagnostics for Nucleic Acids""; ""1.3.1 Homogeneous Colorimetric Assays""; ""1.3.1.1 Unmodified NPs""; ""1.3.1.2 Cross-Linking""; ""1.3.1.3 Noncross-Linking""; ""1.3.2 Heterogeneous Detection""; ""1.3.2.1 Microarrays""
""1.3.2.2 Lateral Flow Assays""""1.3.3 Electrochemical Assays""; ""1.3.4 Fluorescence Assays""; ""1.3.5 Raman and SERS""; ""1.3.6 Other""; ""1.4 Aptamers and Antibodies""; ""1.4.1 Colorimetric""; ""1.4.2 Electrochemical""; ""1.4.3 Lateral Flow Assays""; ""1.5 iPCR and Other Methods""; ""1.6 Conclusion""; ""References""; ""2 Antimicrobial Models in Nanotechnology: From the Selection to Application in the Control and Treatment of Infectious Diseases""; ""2.1 Introduction""; ""2.2 Antimicrobial Susceptibility Testing Methods of NMs""; ""2.2.1 Broth Dilution Test"" ""2.2.2 Spectrophotometric Measurement""""2.2.3 Cell Counting""; ""2.2.4 Colorimetric and Fluorescent Assays""; ""2.2.5 In Vitro Infection Animal Model""; ""2.2.6 Biocidal Testing""; ""2.2.7 Antibiofilm Activity""; ""2.2.8 Quorum-Sensing Inhibitors""; ""2.2.9 Microbial Membrane Lysis""; ""2.2.10 Microbial Oxidative Stress""; ""2.2.11 Antipersister and Antidormancy Bacterial Cells""; ""2.2.12 Microbial Fitness""; ""2.3 Nanotoxicology""; ""2.3.1 Nano-Genotoxicology""; ""2.3.2 Cytotoxicity""; ""2.3.3 Immunotoxicity""; ""2.3.4 In Vitro Skin Irritation"" ""2.3.5 Caenorhabditis elegans Toxicity Model""""2.3.6 Nanotoxicity in Embryonic and Adult Zebrafish""; ""2.3.7 Bioluminescence-Based Nanotoxicity Test""; ""2.4 In Vitro Pharmacokinetics/Pharmacodynamic Models""; ""2.4.1 Particokinetics""; ""2.4.2 Caco-2 Permeability""; ""2.4.3 Hollow Fiber System""; ""2.5 Conclusions""; ""References""; ""3 Silver Nanoparticles for the Control of Vector-Borne Infections""; ""3.1 Introduction""; ""3.2 Louse-Borne Infections and Activity of AgNPs Against Lice""; ""3.3 Mosquito-Borne Infections and Activity of AgNPs Against Mosquitoes"" ""3.4 Tick-Borne Infections and Activity of AgNPs Against Ticks""""3.5 Flies, Their Role in Transmission and Spread of Infections, and Activity of AgNPs Against Flies""; ""3.6 Conclusions and Future Prospects""; ""References""; ""4 Magnetite Nanostructures: Trends in Anti-Infectious Therapy""; ""4.1 Introduction""; ""4.2 Nanoparticles with Biomedical Applications""; ""4.2.1 Design of Tailored Magnetic Nanoparticles with Applications in Microbiology""; ""4.2.2 Magnetite Nanoparticles Used to Control Microorganisms Attachment and Biofilm Formation"" ""4.2.3 The Biocompatibility of Magnetite Nanoparticles"" |
Record Nr. | UNINA-9910797258803321 |
Amsterdam : , : Elsevier, , [2015] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|